dr perlmutter parkinsons treatment glutathione named scientific director of dystonia foundation – WashU Medicine Development of immunotherapy and nanoparticles-based
Development of immunotherapy and nanoparticles based strategies for the treatment of Parkinson's disease Journal of Pharmaceutical Investigation Springer Nature Link Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Multidimensional mechanisms of anxiety and depression in Parkinson's disease: Integrating neuroimaging, neurocircuits, and molecular pathways ScienceDirect Joel Perlmutter, MD Neurology Washington University in St. Louis
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30



